Background: None of the published studies involving cancer cachexia experimental models have included a measure of the severity of the syndrome like the scoring system previously developed for human subjects. The aim of the present investigation was to define and validate a cachexia score usable in both rat and mouse tumor models.
| INTRODUC TI ON
Cancer cachexia is a multi-organic syndrome that affects the majority of cancer patients. It is characterized by both anorexia and metabolic abnormalities that lead to weight loss and, particularly, muscle wasting. It becomes essential, in order to treat cachexia adequately, to assess the cancer patient according to the degree of his/her cachexia. It is for this reason that our research group introduced the so-called CASCO (CAchexia SCOre), 1 for assessing cancer patients.
CASCO was recently validated. 2 None of the published studies involving cancer cachexia experimental models include a measure of the severity of the syndrome like the previously reported CASCO system for human subjects. 1, 2 Therefore, the aim of the present investigation was to define and validate a cachexia score usable in both rats and mice. In order to achieve this goal, the study included one cachexia rat model (Yoshida AH-130 ascites hepatoma) and two mouse models (Lewis lung carcinoma and Colon26 carcinoma).
The score for classifying the degree of cachexia in experimental animals was termed the Animal CAchexia SCOre (ACASCO) and the components of this scoring system are the following: (a) body and muscle weight loss, (b) inflammation and metabolic disturbances, (c) physical performance, (d) anorexia, and (e) quality of life measured using discomfort symptoms and behavioral tests. The components and the details of the measured parameters can be seen in Table 1 and they are based on the components used for the classification of cancer cachexia in human patients. 1, 2 Briefly, body weight loss is an essential component of all definitions of cachexia. 3 Moreover, muscle wasting is the main phenomenon associated with body weight loss. It is therefore important to assess any changes that may occur in muscle mass. The second component of ACASCO includes inflammation and metabolic disturbances. Inflammation is a very important component of the cachectic response. 4, 5 In addition to inflammation, there are a number of metabolic disturbances that are present in most cachectic animals, such as glucose intolerance, anemia and low levels of plasmatic albumin, among others, most of them included in ACASCO (see Table 1 ). The third component relates to physical performance. Even if there is a relatively small decrease in muscle mass due to the cachectic syndrome, there may be a significant decrease in physical activities related to muscle performance. 6, 7 Anorexia (ANO) constitutes the fourth parameter included in ACASCO. Anorexia is an important component of cachexia in many types of diseases. 8, 9 A decrease in food intake, by itself, promotes changes in quality of life and also conditions many metabolic alterations. Finally, the last component of CASCO is quality of life (QoL). Quality of life reflects not just changes in weight and physical performance but also metabolic alterations. 5, 7 It is therefore essential to take it into consideration in the scoring system.
The five different factors mentioned clearly interact with each other and represent the most important set of variables that indicate the severity of the cachectic syndrome. Bearing all this in mind, the results obtained should allow for not only a qualitative but also a quantitative classification of the cachectic syndrome in experimental animals. ACASCO may then be related to different types of treatments according to the severity of cachexia.
| ME THODS

| Experimental tumor models
Five-week-old male Wistar rats (for the AH-130 tumor model), C57BL/6 mice (for LLC tumour model) or Balb/C mice (for C26 tumour model) weighing about 20 g (all from Harlan, Barcelona, Spain) were housed in individual cages and maintained at a constant temperature of 22 ± 2°C with a regular dark-light cycle (light from 08:00 am to 20:00 pm), with free access to food and water during the whole experimental period. All animal manipulations were made in accordance with the European Community guidelines for the use of laboratory animals.
They were cared for in compliance with the Policy on Humane Care and Use of Laboratory Animals (ILAR 2011) and in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. The animals were kept in individual cages for a week prior to the beginning of the experimental protocol (adaptation period). No hyperphagia was observed during this period. All the animals were alive at the end of the experiments. On the day of sacrifice, the animals were weighed and anesthetized with an ip injection of ketamine/xylazine mixture (3:1) (Imalgene® and Rompun® respectively).
Tissues were rapidly excised, weighed, and frozen in liquid nitrogen.
| AH-130 Yoshida ascites hepatoma
Wistar rats were randomized and divided into two groups, namely controls (C) and tumor bearers (TB). Experimental cachexia was obtained through ip injection of 10 8 AH-130 Yoshida ascites hepatoma cells, obtained from exponential tumours, as described previously, 10 into male Wistar rats. On days 2, 4, 6, 8, 10 and 11 after tumor transplantation, the animals were sacrificed and the blood and tissues were rapidly excised for further analysis. Five control rats and six tumor-bearing rats were sacrificed in each time point.
| Lewis lung carcinoma
C57BL/6 mice were randomized and divided into two groups, namely controls (C) and tumor bearers (TB). Mice received an intramuscular (hind leg) inoculum of 5 × 10 5 Lewis lung carcinoma cells obtained from exponential tumors. The Lewis lung carcinoma is a highly cachectic, rapidly growing mouse tumor containing poorly differentiated cells, with a relatively short doubling time. 11 On days 4, 6, 10, 14, 18 and 20 after tumor transplantation, the animals were sacrificed and blood and tissues were rapidly excised for further analysis. Five control mice and six tumor-bearing mice were sacrificed at each time point.
| Colon26 carcinoma
Balb/C mice were randomized and divided into two groups, namely controls (C) and tumor bearers (TB). Tumor-bearing mice were inoculated subcutaneously in the back with 5 × 10 5 Colon26 carcinoma cells. 12 Colon26 cells were maintained in vitro in 
| ACASCO measurements
All the measurements are expressed as a percentage of the difference between non-tumor-bearing animals and tumor-bearing animals, at the time of sacrifice (see Experimental tumor models section).
| Body and muscle weight loss
Body weight was calculated by subtracting the tumor weight from the weight of the tumor-bearing (TB) animal at the moment of sacrifice, and the weight loss was expressed as a percentage the weight of the control group at sacrifice. The criteria used for scoring are depicted in Table 1 and are different for rat and mouse models.
Muscle weight loss was measured as the percentage of gastrocnemius (GSN) muscle weight loss corrected for initial body weight and referenced to the control group (GSN loss = GSN weight of TB group at sacrifice/GSN weight of control group at sacrifice) × 100).
This formula takes into consideration the variation in muscle weight
related to the non-tumor bearing control group. Gastrocnemius muscle was chosen because it is one of the most studied muscles in the experimental cachexia field and its weight reflects cachexia severity. [13] [14] [15] In the case of the rat model, the scoring criteria for body weight loss (BWL) is described in 
| Inflammation and metabolic disturbances
The scoring for inflammation and metabolic disturbances indicated in Table 1 is based on the existence of statistically significant differences in values between the TB and control values. Depending on the metabolite/inflammatory marker the punctuation is different ( Table 1) .
ELISA IL-6 (pg/mL) and SAA (ng/mL) plasma levels were detected using commercially available mouse and rat ELISA kits, according to the manufacturer instructions: mouse IL6 and rat IL-6 kit (Diaclone SAS, France); mouse SAA kit (Abnova, Taiwan); and rat SAA kit (Cusabio Wuhan, China).
Metabolic disturbances
Plasma albumin (g/dL), triacylglycerides (mg/dL) and glucose (mg/ dL) were analyzed using a METROLAB 2300 autoanalyzer, based on analysis of colorimetric reactions.
Hematocrit
Total blood was withdrawn from anesthetized mice by cardiac puncture and collected in heparinized tubes. A drop was used to fill hematocrit capillary tubes, which were centrifuged in a hematocrit centrifuge for 5 minutes at 800g. Hematocrit was calculated as the volume percentage of packed red cell volume in total blood. (Table 1) .
| Physical performance
Grip force assessment
Skeletal muscle strength (handgrip strength) in the experimental animals was quantified by the grip strength test. 17, 18 The grip-strength device (Panlab-Harvard Apparatus, Spain) comprised a pull bar connected to an isometric force transducer (dynamometer). Basically, the grip strength meter was positioned horizontally and the rats and mouse were held by the tail and lowered towards the device.
The animals were allowed to grasp the pull bar and were then pulled backward in the horizontal plane. The force applied to the bar just before the animal lost grip was recorded as the peak tension. At least three measurements were taken per rat on both baseline and test days, and the results were averaged for analysis. Grip force (GF) was measured in g/g initial body weight. 16 The scoring of grip force is indicated in 
| Anorexia
Anorexia was assessed by measuring total food intake (TFI). The scoring is indicated in 
| Quality of life
In order to estimate the quality of life of the animals, several tests were performed.
Discomfort symptoms
The following symptoms were monitored: (a) piloerection, (b) diarrhea or constipation, (c) hunched posture, (d) tremors, (e) closed eyes and (f) red tears (chromodacryorrhea). Points to stablish the score of discomfort symptoms are described in Table 1 : 0-2 symptoms, 0 points; 3-6 symptoms, 0.5 points; 4-6 symptoms, 1 point.
Intruder-resident paradigm
This paradigm is based on the establishment of a territory by a male and its defense against unfamiliar male intruders. It consists of introducing a male, the intruder, into the home cage of another male, the resident, with the former being defeated by the latter. 19 In the cachexia rat model, the interaction time between the intruder and the resident was measured during a 2-minute interval.
The scoring was as follows: a decrease of the interaction compared with the control group of 0-9.99%, 0 points; 10%-30%, 1 point; 31%-60%, 2 points; 61%-100%, 4 points (Table 1 ). In the cachexia mouse models, resident-intruder interaction was evaluated based on rating the level of interest of the resident in the intruder: very interested, 0; interested, 1; little interest, 2; no interest, 4
( Table 1) .
Forced swim test
A container filled with tap water at 26°C to a depth of 30 cm was used to carry out the forced swim test. 20 Animal activity was registered with a video system for 90 seconds. The time during which the animals were trying to escape from the water was registered.
After the test, the rats were dried and returned to their cages.
The scoring was as follows: a decrease in relation to the control group of 0-9.99%, 0 points; 10%-30%, 2 points; 31%-60%, 3 points; 61%-100%, 5 points. The results represent statistical differences observed between the mean values of the different groups. Body weight loss and gastrocnemius (GSN) weight loss calculations are described in the Methods section. Serum amyloid A (SAA) was expressed in ng/mL, IL-6 was expressed in pg/mL, albumin was expressed in g/dL, Triglycerides were expressed in mg/dL, glucose was expressed in mg/dL. Hematocrit was calculated as percentage of packed cell volume to total blood volume. Total physical activity (TPA) was referenced to the control group (TPA = TPA of TB group at sacrifice/mean TPA of the control group at sacrifice) × 100). Handgrip strength or grip force (GF) was measured in g/g initial body weight and the parameter was referenced to the control group (GF = GF of TB group at sacrifice/mean GF of the control group at sacrifice) × 100). Food intake (TFI) was referenced to the control group (TFI = FI of TB group at sacrifice/TFI of the control group at sacrifice) × 100). Discomfort symptoms are described in Table 1 . The intruderresident paradigm and forced swim test were evaluated using a rating scale established to determine the level of interest of the resident-intruder and the time during which the animals were trying to escape from the water, respectively ( Table 1 ). Table 1 depicts the different components of the Animal CAchexia SCOre (ACASCO) system. As can be seen, the body and muscle weight loss score contributes most to the overall score (40%), followed by inflammation and metabolic disturbances (30%) and then, with the same weighting, physical performance (10%), anorexia (10%) and quality of life (10%).
| Statistical analysis
| RE SULTS
The different criteria used to quantify these components are also included in Table 1 , together with the total score of each component.
It can be seen that there are some differences in the scoring system between rats and mice. These include the scoring criteria for weight loss and quality of life (specifically the intruder-resident paradigm).
Comparing ACASCO and CASCO, the measurements of quality of life for experimental animals were based on behavioral tests instead of the typical questionnaires used in humans. 1, 2 Another difference between ACASCO and CASCO relates to one of the measurements of inflammation; serum amyloid A (SAA) used here is the main acute phase protein in rodents while C-reactive protein (CRP) is the equivalent for humans. 21 The rest of the measurements are basically the same between ACASCO and CASCO.
In order to follow the differences in these parameters in the different experimental models used, we have included the data in Tables   2-4 The results represent statistical differences observed between the mean values of the different groups. Body weight loss and gastrocnemius (GSN) weight loss calculations are described in the Methods section. Serum amyloid A (SAA) was expressed in ng/mL, IL-6 was expressed in pg/mL, albumin was expressed in g/dL, Triglycerides were expressed in mg/dL, glucose was expressed in mg/dL. Hematocrit was calculated as percentage of packed cell volume to total blood volume. Total physical activity (TPA) was referenced to the control group (TPA = TPA of TB group at sacrifice/mean TPA of the control group at sacrifice) × 100). Handgrip strength or grip force (GF) was measured in g/g initial body weight and the parameter was referenced to the control group (GF = GF of TB group at sacrifice/mean GF of the control group at sacrifice) × 100). Food intake (TFI) was referenced to the control group (TFI = FI of TB group at sacrifice/TFI of the control group at sacrifice) × 100). Discomfort symptoms are described in Table 1 . The intruderresident paradigm and forced swim test were evaluated using a rating scale established to determine the level of interest of the resident-intruder and the time during which the animals were trying to escape from the water, respectively (Table 1 ).
described, one exactly below the observed mean, the second exactly over the mean, and the third and fourth groups adjusted to every cue (inferior and superior). The three cut-off values were estimated through maximization of the classification function. This was accomplished by using a similarity matrix based on the metric properties of the variables and assuming multinormal distribution.
The results show that the four groups represented: no cachexia, mild cachexia, moderate cachexia, and advanced cachexia. The data for the different models are represented in Figure 1 with the scoring scale going from 0 to 100. The intervals for each group show slight variations indicated in Figure 1 In consequence, depending on the tumor model the classification of the severity of cachexia will be different: in the rat model, the score indicating the presence of cachexia was lower (>10) than in the mouse models, where cachexia was only detectable at higher scores (>15 for C26 and >22 for LLC). Interestingly, advanced cachexia was indicated by a score of approximately 65 points in the mouse models, while in the rat model cachexia was present at >53 points.
Validation of the scores was performed by establishing a correlation with tumor weight. Figure 2 shows the different correlations between the cluster-analysis-established groups and the weight of the tumor for each of the tumor models included in this study. Very good correlations were seen for all of them, thereby validating the methodology used in ACASCO ( Figure 2 ; A, Yoshida AH-130 ascites hepatoma; B, Lewis lung carcinoma; C, Colon26 carcinoma).
| D ISCUSS I ON
In summary, the present investigation represents an extension of the cachexia score developed for humans: a quantitative design for classification of the cachectic syndrome in experimental animals. It is interesting to note that, as in humans, 1, 2 The results represent statistical differences observed between the mean values of the different groups. Body weight loss and gastrocnemius (GSN) weight loss calculations are described in the Methods section. Serum amyloid A (SAA) was expressed in ng/mL, IL-6 was expressed in pg/mL, albumin was expressed in g/dL, Triglycerides were expressed in mg/dL, glucose was expressed in mg/dL. Hematocrit was calculated as percentage of packed cell volume to total blood volume. Total physical activity (TPA) was referenced to the control group (TPA = TPA of TB group at sacrifice/mean TPA of the control group at sacrifice) × 100). Handgrip strength or grip force (GF) was measured in g/g initial body weight and the parameter was referenced to the control group (GF = GF of TB group at sacrifice/mean GF of the control group at sacrifice) × 100). Food intake (TFI) was referenced to the control group (TFI = FI of TB group at sacrifice/TFI of the control group at sacrifice) × 100). Discomfort symptoms are described in Table 1 . The intruderresident paradigm and forced swim test were evaluated using a rating scale established to determine the level of interest of the resident-intruder and the time during which the animals were trying to escape from the water, respectively ( Table 1) 
| CON CLUS IONS
The results obtained allow us to conclude that the score system will be very useful as an endpoint in pre-clinical studies involving therapeutic strategies for cancer cachexia. The potential benefit of the use of ACASCO relates to establishing the primary endpoint in preclinical cancer cachexia drug evaluations.
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